Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)
Today, Bank of America Corporation reiterated its Buy rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $36.00.
There are 1 hold rating, 5 buy ratings on the stock.
The current consensus rating on Ascendis Pharma A/S (NASDAQ:ASND) is Buy (Score: 2.83) with a consensus target price of $35.29 per share, a potential 3.05% upside.
Some recent analyst ratings include
- 9/25/2017-Bank of America Corporation Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo & Company Reiterated Rating of Buy.
- 9/22/2017-Credit Suisse Group Reiterated Rating of Outperform.
- 9/22/2017-Wedbush Reiterated Rating of Outperform.
- 9/1/2017-Leerink Swann Reiterated Rating of Hold.
- 5/11/2017-J P Morgan Chase & Co initiated coverage with a Overweight rating.
Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
Shares of Ascendis Pharma A/S closed the previous trading session at with shares trading hands.
